DLL3 is a cell surface protein expressed in neuroendocrine tumors (notably small cell lung cancer (SCLC) and NEPC) but not in normal adult tissues, making it an ideal immunotherapeutic target in this context. The gene discussed is DLL3; the disease is neuroendocrine neoplasm.